Nakashima H - Search Results

1

Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primates.

Yao Y, Wang J, Liu Y, Qu Y, Wang K, Zhang Y, Chang Y, Yang Z, Wan J, Liu J, Nakashima H, Lawler SE, Chiocca EA, Cho CF, Bei F. Yao Y, et al. Among authors: nakashima h. Nat Biomed Eng. 2022 Nov;6(11):1257-1271. doi: 10.1038/s41551-022-00938-7. Epub 2022 Oct 10. Nat Biomed Eng. 2022. PMID: 36217021

2

Directing systemic oncolytic viral delivery to tumors via carrier cells.

Nakashima H, Kaur B, Chiocca EA. Nakashima H, et al. Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):119-26. doi: 10.1016/j.cytogfr.2010.02.004. Epub 2010 Mar 11. Cytokine Growth Factor Rev. 2010. PMID: 20226717 Free PMC article. Review.

3

Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs.

Kasai K, Nakashima H, Liu F, Kerr S, Wang J, Phelps M, Potter PM, Goins WB, Fernandez SA, Chiocca EA. Kasai K, et al. Among authors: nakashima h. Mol Ther Nucleic Acids. 2013 Aug 6;2(8):e113. doi: 10.1038/mtna.2013.38. Mol Ther Nucleic Acids. 2013. PMID: 23922029 Free PMC article.

4

Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.

Nakashima H, Chiocca EA. Nakashima H, et al. J Virol. 2014 Jan;88(1):345-53. doi: 10.1128/JVI.02668-13. Epub 2013 Oct 23. J Virol. 2014. PMID: 24155386 Free PMC article.

5

Modification of HSV-1 to an oncolytic virus.

Nakashima H, Chiocca EA. Nakashima H, et al. Methods Mol Biol. 2014;1144:117-27. doi: 10.1007/978-1-4939-0428-0_8. Methods Mol Biol. 2014. PMID: 24671680

6

Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62.

Nakashima H, Nguyen T, Goins WF, Chiocca EA. Nakashima H, et al. J Biol Chem. 2015 Jan 16;290(3):1485-95. doi: 10.1074/jbc.M114.593871. Epub 2014 Nov 26. J Biol Chem. 2015. PMID: 25429107 Free PMC article.

7

Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy.

Nakashima H, Nguyen T, Chiocca EA. Nakashima H, et al. Oncolytic Virother. 2015 Nov 20;4:183-91. doi: 10.2147/OV.S66081. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512681 Free PMC article. Review.

8

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.

Speranza MC, Passaro C, Ricklefs F, Kasai K, Klein SR, Nakashima H, Kaufmann JK, Ahmed AK, Nowicki MO, Obi P, Bronisz A, Aguilar-Cordova E, Aguilar LK, Guzik BW, Breakefield X, Weissleder R, Freeman GJ, Reardon DA, Wen PY, Chiocca EA, Lawler SE. Speranza MC, et al. Among authors: nakashima h. Neuro Oncol. 2018 Jan 22;20(2):225-235. doi: 10.1093/neuonc/nox139. Neuro Oncol. 2018. PMID: 29016938 Free PMC article.

9

Modeling tumor immunity of mouse glioblastoma by exhausted CD8⁺ T cells.

Nakashima H, Alayo QA, Penaloza-MacMaster P, Freeman GJ, Kuchroo VK, Reardon DA, Fernandez S, Caligiuri M, Chiocca EA. Nakashima H, et al. Sci Rep. 2018 Jan 9;8(1):208. doi: 10.1038/s41598-017-18540-2. Sci Rep. 2018. PMID: 29317703 Free PMC article.

10

Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.

Nakashima H, Nguyen T, Kasai K, Passaro C, Ito H, Goins WF, Shaikh I, Erdelyi R, Nishihara R, Nakano I, Reardon DA, Anderson AC, Kuchroo V, Chiocca EA. Nakashima H, et al. Clin Cancer Res. 2018 Jun 1;24(11):2574-2584. doi: 10.1158/1078-0432.CCR-17-2954. Epub 2018 Mar 6. Clin Cancer Res. 2018. PMID: 29511029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,879 results

Search Page